We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-10.59%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$44.5M
AUM Growth
-$42.1M
Cap. Flow
-$53.2M
Cap. Flow %
-119.42%
Top 10 Hldgs %
85.41%
Holding
81
New
17
Increased
1
Reduced
6
Closed
38

Top Buys

Rank Stock Value
1
OCGN icon
Ocugen
OCGN
+$4.57M
2
XCUR icon
Exicure
XCUR
+$3.25M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$3M
4
TEUM
Pareteum Corporation
TEUM
+$2.51M
5
CRMD icon
CorMedix
CRMD
+$1.93M

Top Sells

Rank Stock Value
1
SCOR icon
Comscore
SCOR
+$14.1M
2
MDCO
Medicines Co
MDCO
+$4.12M
3
CARM
Carisma Therapeutics
CARM
+$3.95M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$3.74M
5
CALA
Calithera Biosciences, Inc
CALA
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 39.19%
2 Technology 6.18%
3 Communication Services 3.83%
4 Consumer Discretionary 1.4%
5 Materials 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CARM
1
DELISTED
Carisma Therapeutics
CARM
$5.54M 12.44%
236,899
-168,745
-42% -$3.95M
XCUR icon
2
Exicure
XCUR
$11M
$3.23M 7.24%
+8,503
New +$3.25M
TPTX
3
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2.59M 5.81%
+68,841
New +$3M
VUZI icon
4
Vuzix
VUZI
$178M
$1.52M 3.42%
+667,565
New +$1.54M
EMWP
5
DELISTED
Eros Media World PLC
EMWP
$1.5M 3.36%
39,169
-65,761
-63% -$2.34M
CRMD icon
6
CorMedix
CRMD
$564M
$1.46M 3.29%
+229,465
New +$1.93M
TEUM
7
DELISTED
Pareteum Corporation
TEUM
$1.23M 2.77%
+955,486
New +$2.51M
BTAI icon
8
BioXcel Therapeutics
BTAI
$24.8M
$1.12M 2.51%
+9,937
New +$1.57M
NTBL
9
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$1.11M 2.5%
23,546
-2,419
-9% -$107K
OCGN icon
10
Ocugen
OCGN
$403M
$1.06M 2.38%
+368,315
New +$4.57M
TCOM icon
11
Trip.com Group
TCOM
$29B
$624K 1.4%
+21,308
New +$749K
DMK
12
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$622K 1.4%
+12,620
New +$907K
AUMN
13
DELISTED
Golden Minerals Company
AUMN
$435K 0.98%
+71,277
New +$462K
ARCT icon
14
Arcturus Therapeutics
ARCT
$165M
$227K 0.51%
+22,081
New +$239K
OPRA
15
Opera Ltd
OPRA
$1.68B
$212K 0.48%
+21,109
New +$240K
BLCM
16
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$177K 0.4%
+16,874
New +$221K
AIHS icon
17
Senmiao Technology Ltd
AIHS
$20.1M
$150K 0.34%
4,036
+53
+1% +$5.4K
FAMI icon
18
Farmmi Inc
FAMI
$5.61M
$136K 0.31%
36
-6
-14% -$20.5K
PSTV icon
19
Plus Therapeutics
PSTV
$25M
$134K 0.3%
+104
New +$376K
HURA
20
TuHURA Biosciences
HURA
$130M
$104K 0.23%
+108
New +$203K
VERBW
21
DELISTED
Verb Technology Company, Inc. Warrant
VERBW
$88K 0.2%
240,000
– –
SEEL
22
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$54K 0.12%
+15
New +$90.4K
SGLBW
23
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$52K 0.12%
199,836
– –
BVXVW
24
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$45K 0.1%
72,800
– –
ARTLW
25
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$38K 0.09%
65,000
– –
1
2 3 4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q3 2019 Portfolio in Review

As of Q3 2019, CVI Holdings held 81 positions worth $44.5M, down 49% from $86.6M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

CVI Holdings withdrew a net $53.2M in Q3 2019, closing 38 positions and reducing 6 holdings. Its most notable exit was Comscore, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, CVI Holdings opened a new position in Ocugen worth $1.06M.

  • CVI Holdings's largest Q3 2019 buy was Ocugen: 368,315 shares worth $1.06M.
  • CVI Holdings added most to Senmiao Technology Ltd in Q3 2019, an estimated $5.4K increase.
  • CVI Holdings's biggest Q3 2019 reduction was Carisma Therapeutics, cutting an estimated $3.95M.
  • CVI Holdings fully exited Comscore in Q3 2019, selling an estimated $14.1M.
  • CVI Holdings's ten largest holdings make up 85% of its $44.5M portfolio in Q3 2019.
  • CVI Holdings opened 17 new positions and closed 38 in Q3 2019.
  • CVI Holdings's portfolio value fell 49% quarter-over-quarter to $44.5M.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.